Healthcare Startup BeatO bags $33 M funds in Series B funding round backed by Light rock India. HealthQuad, Flipkart Ventures and many other existing investors also participated in this funding round.

Flipkart Ventures has invested an undisclosed amount of funds in the round.

BeatO targets to treat more than 10 million diabetic patients by 2025. Interestingly, the company aims at this target only by focusing on tier 2 and 3 markets.

As per company reports, most users belong to tier 2 cities. Around 70% of its users are from tier 2 cities.

This Diabetes Care startup will mostly utilize the funds to elevate the digital platform and invest in the product. In addition to this, the startup also looks forward to increase the reach of its evidence-based care programs. It wants to strengthen its core leadership team for betterment of the people.

Company serves more than 15 lakhs members in the platform. Additionally, it also claims to have grown 3x in the last year.

BeatO Background and Facilities

The founders of BeatO are Yash Sehgal, Gautam Chopra and Kunal kinalekar. BeatO is an app-based platform that helps patients to control and reverse diabetes. It is a healthcare startup that primarily focuses on diabetes care.

BeatO is a digitally accessible platform for controlling and reversing diabetes. It also has a facility to connect to smartphones for telling insights into the body’s health.

Previous Fundings and Rivals

Apart from this round, where BeatO bags $33 M funds, this diabetes-focused startup has previously raised many funding rounds. The startup has received funds from Alteria Capital, W Health Global and Kotak Investment Advisors.

There is a facility for the customers to check glucose levels. Accu-Check, MDAcne and others stand against in rivalry with BeatO. India is all ready to become the diabetes capital of the world with more than 200 million people at risk.

Featured Image Credit: BusinessWorld

Apurv Panigrahi